tiprankstipranks
Advertisement
Advertisement

TAK Stock Latest News

Takeda announces results for Phase 3 study of TAK-279
The FlyTakeda announces results for Phase 3 study of TAK-279
5h ago
TAK
FDA accepts Takeda’s application for intravenous Entyvio
PremiumThe Fly
FDA accepts Takeda’s application for intravenous Entyvio
2d ago
TAK
Takeda’s TAK-360 Narcolepsy Trial Moves Forward, Expanding Its Specialty CNS Pipeline
PremiumCompany Announcements
Takeda’s TAK-360 Narcolepsy Trial Moves Forward, Expanding Its Specialty CNS Pipeline
2d ago
TAK
Takeda’s New Mezagitamab Trial Targets High-Risk Kidney Rejection, Bolstering Long-Term Pipeline Story
PremiumCompany Announcements
Takeda’s New Mezagitamab Trial Targets High-Risk Kidney Rejection, Bolstering Long-Term Pipeline Story
7d ago
TAK
Takeda’s Real-World Maribavir Study in Argentina: What Investors Should Watch
PremiumCompany Announcements
Takeda’s Real-World Maribavir Study in Argentina: What Investors Should Watch
7d ago
TAK
Innovent Biologics announces results from PoC study of IBI363
PremiumThe FlyInnovent Biologics announces results from PoC study of IBI363
11d ago
TAK
Takeda to Revise FY2025 IFRS Earnings Report After U.S. AMITIZA Antitrust Verdict
Premium
Company Announcements
Takeda to Revise FY2025 IFRS Earnings Report After U.S. AMITIZA Antitrust Verdict
16d ago
6K
TAK
Takeda Links Executive Pay to R&D Progress and TSR as FY2025 Results Reset Growth Path
Premium
Company Announcements
Takeda Links Executive Pay to R&D Progress and TSR as FY2025 Results Reset Growth Path
16d ago
6K
TAK
Takeda CEO-Elect Julie Kim Sets Two-Horizon Growth Plan on Back of Strong FY2025 Pipeline and Results
PremiumCompany Announcements
Takeda CEO-Elect Julie Kim Sets Two-Horizon Growth Plan on Back of Strong FY2025 Pipeline and Results
16d ago
6K
TAK
Takeda Details IFRS-Based Financial Notes and Group Restructuring in May 2026 Filing
PremiumCompany Announcements
Takeda Details IFRS-Based Financial Notes and Group Restructuring in May 2026 Filing
16d ago
6K
TAK
Takeda Sets June 24, 2026 Date for 150th Shareholders’ Meeting and Details Governance Agenda
PremiumCompany Announcements
Takeda Sets June 24, 2026 Date for 150th Shareholders’ Meeting and Details Governance Agenda
16d ago
6K
TAK
Takeda Expands Maribavir Into Pediatric CMV, Extending Long-Term Upside Potential
PremiumCompany Announcements
Takeda Expands Maribavir Into Pediatric CMV, Extending Long-Term Upside Potential
20d ago
TAK
Takeda Expands Real-World Data on OBIZUR, Supporting Its Rare Disease Strategy
PremiumCompany AnnouncementsTakeda Expands Real-World Data on OBIZUR, Supporting Its Rare Disease Strategy
20d ago
TAK
Takeda Earnings Call: Pipeline Strength Amid Profit Squeeze
Premium
Company Announcements
Takeda Earnings Call: Pipeline Strength Amid Profit Squeeze
21d ago
TAK
Jury finds Takeda caused about $885M in damages over generic delay, Reuters says
Premium
The Fly
Jury finds Takeda caused about $885M in damages over generic delay, Reuters says
24d ago
TAK
Takeda told to pay hundreds of millions for generic drug delay, Bloomberg says
PremiumThe Fly
Takeda told to pay hundreds of millions for generic drug delay, Bloomberg says
24d ago
TAK
Takeda ordered by pay hundreds of millions in antitrust case, Bloomberg says
PremiumThe Fly
Takeda ordered by pay hundreds of millions in antitrust case, Bloomberg says
24d ago
TAK
Trump Trade: Trump says Xi agreed to buy 200 jets from Boeing
PremiumThe Fly
Trump Trade: Trump says Xi agreed to buy 200 jets from Boeing
27d ago
BA
SPY
Justice Department announces $13.67M civil settlement with Takeda
PremiumThe Fly
Justice Department announces $13.67M civil settlement with Takeda
28d ago
TAK
These Are the Stocks Reporting Earnings Today – May 13, 2026
PremiumMarket NewsThese Are the Stocks Reporting Earnings Today – May 13, 2026
29d ago
MFC
STN
TAK Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
TAK Upcoming Earnings Report: What to Expect?
1M ago
TAK
Takeda Advances TAK-279 Into Phase 2a Crohn’s Study, Signaling Long-Term GI Growth Ambitions
Premium
Company Announcements
Takeda Advances TAK-279 Into Phase 2a Crohn’s Study, Signaling Long-Term GI Growth Ambitions
1M ago
TAK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >